|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9910462082103321 |
|
|
Titolo |
Envisioning a transformed clinical trials enterprise in the United States [[electronic resource] ] : establishing an agenda for 2020: workshop summary / / Neil Weisfeld, Rebecca A. English, and Anne B. Claiborne, rapporteurs; Forum on Drug Discovery, Development, and Translation; Board on Health Sciences Policy |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Washington, : National Academies Press, 2012 |
|
|
|
|
|
|
|
ISBN |
|
1-283-63636-0 |
0-309-25316-0 |
|
|
|
|
|
|
|
|
Descrizione fisica |
|
1 online resource (232 p.) |
|
|
|
|
|
|
Altri autori (Persone) |
|
WeisfeldNeil E |
EnglishRebecca A |
ClaiborneAnne B |
|
|
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Clinical trials - United States |
Clinical medicine - Research - United States |
Electronic books. |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Description based upon print version of record. |
|
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references. |
|
|
|
|
|
|
Nota di contenuto |
|
""Front Matter""; ""Reviewers""; ""Contents""; ""Tables, Figures, and Boxes""; ""Acronyms""; ""1 Introduction""; ""2 Integrating Community Practice and Clinical Trials""; ""3 Improving Public Participation in Clinical Trials""; ""4 Creating a New Business Model for Clinical Trials""; ""5 Building an Infrastructure to Support Clinical Trials""; ""6 Suggesting an Agenda for Transforming Elements of the Clinical Trials Enterprise""; ""References""; ""Appendix A: Workshop Agenda""; ""Appendix B: Participant Biographies""; ""Appendix C: Registered Workshop Attendees"" |
""Appendix D: Discussion Paper: The Clinical Trials Enterprise in the United States: A Call for Disruptive Innovation""""Appendix E: Discussion Paper: Developing a Robust Clinical Trials Workforce""; ""Appendix F: Discussion Paper: Transforming the Economics of Clinical Trials""; ""Appendix G: Discussion Paper: Developing a Clinical Trials Infrastructure""; ""Appendix H: Discussion Paper: Canadian Strategy on |
|
|
|
|